Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
- Moody's upgraded Teva Pharmaceuticals' corporate credit rating to Ba1 from Ba2 with a stable outlook on May 15, 2025, in Tel Aviv, Israel.
- Moody's upgraded Teva's credit rating, highlighting the company's extensive international presence, expansion of its branded product lines, stabilization in its generics segment, ongoing efforts to reduce debt, and progress in addressing legal challenges.
- Teva's Chief Financial Officer Eli Kalif stated the upgrade reflects consistent performance driven by the company's Pivot to Growth strategy focused on portfolio and cost improvements.
- The upgrade is expected to lower Teva's cost of debt and enhance access to a broader investor base, supporting business expansion and financial stability.
- This rating improvement signals confidence in Teva's global operations, innovation pipeline, and ongoing transformation, while forward-looking statements note potential risks and uncertainties.
Insights by Ground AI
Does this summary seem wrong?
11 Articles
11 Articles
All
Left
8
Center
Right
1

+5 Reposted by 5 other sources
Moody’s Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody's Investor Services (“Moody's”) has raised the company's corporate credit rating to Ba1, outlook stable; from Ba2, outlook positive.
·Welland, Canada
Read Full Article
+3 Reposted by 3 other sources
Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody's Investor Services (“Moody's”) has raised the company's corporate credit rating to Ba1, outlook stable; from Ba2, outlook positive.
·Muskoka Lakes, Canada
Read Full ArticleCoverage Details
Total News Sources11
Leaning Left8Leaning Right1Center0Last UpdatedBias Distribution89% Left
Bias Distribution
- 89% of the sources lean Left
89% Left
L 89%
11%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage